Table 5.

Treatment efficacy monitoring program

Variable	Induction therapy	Maintenance therapy
Liver biochemistry	Every 1–3 months	Every 6 months–1 year
Serum IgG	Every 1–3 months	Every 6 months–1 year
Serum autoantibodies	Every 3 months	Every 6 months–1 year
HCC-associated tumor markers	Every 6 months
Abdominal ultrasonography	Every 1 year
Transient elastography	Every 1 year
Liver biopsy	Non-response, incomplete response, before the treatment withdrawal